東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Neuroprotection in Alzheimer's disease

Gozes, Illana,

FindBook

Google Book

Amazon

博客來

Neuroprotection in Alzheimer's disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Neuroprotection in Alzheimer's disease/ edited by Illana Gozes.
其他作者:	Gozes, Illana,
出版者:	London, United Kingdom :Academic Press, : 2017.,
面頁冊數:	1 online resource
內容註:	Cover; Title page; Copyright Page; Dedication; Contents; List of Contributors; Acknowledgments; Chapter 1 -- Introduction; Chapter 2 -- Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer's Disease; Introduction; Global health care burden of Alzheimer's disease: epidemiological data; Etiopathogenesis of Alzheimer's disease: what do we know?; Therapeutic approaches to Alzheimer's disease: the promises, the failures, and the future; Neural regeneration-based therapeutic approach for AD: the rationale, the promise, and the progress.
內容註:	Neurotrophic factor small-molecule mimetics for Alzheimer's diseaseEnhancement of neurogenesis and memory by CNTF small-molecule mimetics; CNTF-derived neurogenic/neurotrophic compound, P021, can exert a disease-modifying effect in a transgenic mouse model of AD; Summary and conclusions; References; Chapter 3 -- Animal Models of Alzheimer's Disease; Introduction; The genetics of Alzheimer's disease; Transgenic models of amyloidogenesis; Amyloid precursor protein transgenic mice; PDAPP transgenic mice; Histopathology; Behavior; Synaptic Plasticity; Tg2576 transgenic mice; Histopathology.
內容註:	BehaviorSynaptic Plasticity; APP23 transgenic mice; Histopathology; Behavior; Synaptic Plasticity; J20 transgenic mice; Histopathology; Behavior; Synaptic Plasticity; APP knock-in transgenic mice; Histopathology; Behavior; Synaptic Plasticity; APP/PS1 transgenic mice; Histopathology; Behavior; Synaptic Plasticity; 5xFAD transgenic mice; Histopathology; Behavior; Synaptic Plasticity; Tau transgenic mice; Tau tg mice under tau promoter; Histopathology; Behavior; Synaptic Plasticity; 3xTg transgenic mice; Histopathology; Behavior; Synaptic Plasticity; Animal models for late onset of AD.
內容註:	ApoE Transgenic MiceApoE Knock-Out Transgenic Mice; ApoE2/ApoE3/ApoE4 Knock-In Transgenic Mice; GFAP-ApoE4/ApoE Knock-Out Transgenic Mice; ApoE/APP Transgenic Mice; Nonmouse models; Studies in nematodes; Studies in fruit flies; Nontransgenic models for the study of AD; How to choose the right model?; Summary; Acknowledgment; References; Chapter 4 -- Mechanisms of Neuronal Microtubule Loss in Alzheimer's Disease; Introduction; Studies on Alzheimer's brain and animal models; Are microtubules destabilized in the Alzheimer's brain?; Mechanisms of microtubule loss in the Alzheimer's brain.
內容註:	Strategies for treatmentAcknowledgments; References; Chapter 5 -- Tau-Centric Therapies for Treating Alzheimer's Disease; Introduction; Six Tau Isoforms-Many Tau Functions; Mechanisms of Tau Toxicity: Phosphorylation, Microtubule Destabilization, and Aggregation; Tau-centric therapeutic strategy 1: targeting tau phosphorylation; Tau Phosphorylation in Physiological and Pathological States; Mechanisms for Stimulating Tau Phosphorylation; Consequences of Phosphorylation; Therapeutic Strategies to Inhibit Tau Phosphorylation; Current State of Affairs.
標題:	Alzheimer's disease. -
電子資源:	https://www.sciencedirect.com/science/book/9780128036907
ISBN:	9780128037126 (electronic bk.)

Neuroprotection in Alzheimer's disease
Neuroprotection in Alzheimer's disease[electronic resource] /edited by Illana Gozes. - London, United Kingdom :Academic Press,2017. - 1 online resource

Cover; Title page; Copyright Page; Dedication; Contents; List of Contributors; Acknowledgments; Chapter 1 -- Introduction; Chapter 2 -- Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer's Disease; Introduction; Global health care burden of Alzheimer's disease: epidemiological data; Etiopathogenesis of Alzheimer's disease: what do we know?; Therapeutic approaches to Alzheimer's disease: the promises, the failures, and the future; Neural regeneration-based therapeutic approach for AD: the rationale, the promise, and the progress.

ISBN: 9780128037126 (electronic bk.)Subjects--Topical Terms:

588010
Alzheimer's disease.
Index Terms--Genre/Form:

3509813
Computer network resources.

LC Class. No.: RC523

Dewey Class. No.: 616.8/311

National Library of Medicine Call No.: 2017 D-046

Neuroprotection in Alzheimer's disease
LDR:03899cmm a2200301 a 4500 001 2246427
006 m o d
007 cr |n|||||||||
008 211224s2017 enk o 001 0 eng d
020 $a 9780128037126 (electronic bk.)
020 $a 0128037121 (electronic bk.)
020 $a 9780128036907
020 $a 0128036907
035 $a ocn967683802
040 $a YDX $b eng $e pn $c YDX $d N$T $d IDEBK $d EBLCP $d OPELS $d N$T $d OCLCF $d OCLCQ $d UPM $d OCLCQ $d COO $d OCLCO $d MERER $d OCLCQ $d OTZ $d OCLCQ $d OCLCA $d D6H $d DKU $d U3W $d CNCGM $d Z5A $d CASUM $d UAB $d LVT $d AU@ $d OCLCO $d OCLCQ $d OCLCO $d S2H $d OCLCO $d OCLCA
041 0 $a eng
050 4 $a RC523
060 4 $a 2017 D-046
060 4 $a WT 155
082 0 4 $a 616.8/311 $2 23
245 0 0 $a Neuroprotection in Alzheimer's disease $h [electronic resource] / $c edited by Illana Gozes.
260 $a London, United Kingdom : $b Academic Press, $c 2017.
300 $a 1 online resource
505 0 $a Cover; Title page; Copyright Page; Dedication; Contents; List of Contributors; Acknowledgments; Chapter 1 -- Introduction; Chapter 2 -- Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer's Disease; Introduction; Global health care burden of Alzheimer's disease: epidemiological data; Etiopathogenesis of Alzheimer's disease: what do we know?; Therapeutic approaches to Alzheimer's disease: the promises, the failures, and the future; Neural regeneration-based therapeutic approach for AD: the rationale, the promise, and the progress.
505 8 $a Neurotrophic factor small-molecule mimetics for Alzheimer's diseaseEnhancement of neurogenesis and memory by CNTF small-molecule mimetics; CNTF-derived neurogenic/neurotrophic compound, P021, can exert a disease-modifying effect in a transgenic mouse model of AD; Summary and conclusions; References; Chapter 3 -- Animal Models of Alzheimer's Disease; Introduction; The genetics of Alzheimer's disease; Transgenic models of amyloidogenesis; Amyloid precursor protein transgenic mice; PDAPP transgenic mice; Histopathology; Behavior; Synaptic Plasticity; Tg2576 transgenic mice; Histopathology.
505 8 $a BehaviorSynaptic Plasticity; APP23 transgenic mice; Histopathology; Behavior; Synaptic Plasticity; J20 transgenic mice; Histopathology; Behavior; Synaptic Plasticity; APP knock-in transgenic mice; Histopathology; Behavior; Synaptic Plasticity; APP/PS1 transgenic mice; Histopathology; Behavior; Synaptic Plasticity; 5xFAD transgenic mice; Histopathology; Behavior; Synaptic Plasticity; Tau transgenic mice; Tau tg mice under tau promoter; Histopathology; Behavior; Synaptic Plasticity; 3xTg transgenic mice; Histopathology; Behavior; Synaptic Plasticity; Animal models for late onset of AD.
505 8 $a ApoE Transgenic MiceApoE Knock-Out Transgenic Mice; ApoE2/ApoE3/ApoE4 Knock-In Transgenic Mice; GFAP-ApoE4/ApoE Knock-Out Transgenic Mice; ApoE/APP Transgenic Mice; Nonmouse models; Studies in nematodes; Studies in fruit flies; Nontransgenic models for the study of AD; How to choose the right model?; Summary; Acknowledgment; References; Chapter 4 -- Mechanisms of Neuronal Microtubule Loss in Alzheimer's Disease; Introduction; Studies on Alzheimer's brain and animal models; Are microtubules destabilized in the Alzheimer's brain?; Mechanisms of microtubule loss in the Alzheimer's brain.
505 8 $a Strategies for treatmentAcknowledgments; References; Chapter 5 -- Tau-Centric Therapies for Treating Alzheimer's Disease; Introduction; Six Tau Isoforms-Many Tau Functions; Mechanisms of Tau Toxicity: Phosphorylation, Microtubule Destabilization, and Aggregation; Tau-centric therapeutic strategy 1: targeting tau phosphorylation; Tau Phosphorylation in Physiological and Pathological States; Mechanisms for Stimulating Tau Phosphorylation; Consequences of Phosphorylation; Therapeutic Strategies to Inhibit Tau Phosphorylation; Current State of Affairs.
650 0 $a Alzheimer's disease. $3 588010
650 0 $a Alzheimer's disease $x Prevention. $3 2200371
650 1 2 $a Alzheimer Disease $x prevention & control. $3 3509811
650 2 2 $a Neuroprotection. $3 3509812
650 7 $a HEALTH & FITNESS $x Diseases $x General. $2 bisacsh $3 1614811
650 7 $a MEDICAL $x Clinical Medicine. $2 bisacsh $3 1457888
650 7 $a MEDICAL $x Diseases. $2 bisacsh $3 1614812
650 7 $a MEDICAL $x Evidence-Based Medicine. $2 bisacsh $3 1615052
650 7 $a MEDICAL $x Internal Medicine. $2 bisacsh $3 1615053
655 0 $a Computer network resources. $3 3509813
655 4 $a Fulltext. $3 3509814
655 4 $a Internet Resources. $3 3509815
700 1 $a Gozes, Illana, $e editor. $3 3509810
856 4 0 $u https://www.sciencedirect.com/science/book/9780128036907